Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Patent

Business news
Regional

PowerBridge Expands Energy Patent Holdings With Enphase Deal

June 6, 2026June 5, 2026 - by Timothy Alexander

READING, PA — PowerBridge Networks has acquired more than 50 patents and patent applications from Enphase Energy, expanding its intellectual property portfolio in energy infrastructure technologies as competition intensifies around …

PowerBridge Expands Energy Patent Holdings With Enphase Deal Read More

Palvella Therapeutics
Products and Services

Palvella Secures Patent Protection Ahead of Rare Skin Trial

June 3, 2026June 2, 2026 - by Timothy Alexander

WAYNE, PA — Palvella Therapeutics (Nasdaq: PVLA) has secured a new U.S. patent covering a key treatment approach for porokeratosis, strengthening its intellectual property position as the company prepares to …

Palvella Secures Patent Protection Ahead of Rare Skin Trial Read More
sfa therapeutics
Regional

SFA Therapeutics Extends Patent Protection for Drug Platform

May 31, 2026May 30, 2026 - by Timothy Alexander

JENKINTOWN, PA — SFA Therapeutics has secured a new U.S. patent covering a class of modified short-chain fatty acid compounds, strengthening intellectual property protection around its drug development platform and …

SFA Therapeutics Extends Patent Protection for Drug Platform Read More

Annovis Bio
Business

Annovis Secures U.S. Patent for Buntanetap Neurological Use

April 8, 2026April 7, 2026 - by Timothy Alexander

MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has received a U.S. patent covering the use of its drug candidate buntanetap to prevent and treat neurological injuries linked to brain …

Annovis Secures U.S. Patent for Buntanetap Neurological Use Read More
Palvella Therapeutics
Business

European Patent Office Grants Palvella Patent for QTORIN Rapamycin

March 24, 2026March 23, 2026 - by Timothy Alexander

WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) said the European Patent Office has granted a patent covering its lead product candidate QTORIN 3.9% rapamycin gel, extending intellectual property protection …

European Patent Office Grants Palvella Patent for QTORIN Rapamycin Read More

Windtree Therapeutics
Regional

Windtree Expands Global Patent Portfolio as Heart Failure Pipeline Gains Momentum

November 20, 2025November 18, 2025 - by Timothy Alexander

WARRINGTON, PA — Windtree Therapeutics, Inc. (OTCID: WINT) has strengthened its intellectual property position with newly allowed and granted patents in Canada, Mexico, and Israel, reinforcing the company’s long-term strategy …

Windtree Expands Global Patent Portfolio as Heart Failure Pipeline Gains Momentum Read More
Main Line Health
Regional

Main Line Health Researcher Patents New Tools To Detect and Prevent Lyme Disease

August 31, 2025August 30, 2025 - by Timothy Alexander

WYNNEWOOD, PA — A researcher with Main Line Health has secured a U.S. patent for protein fragments that could be used to both detect and prevent Lyme disease, offering hope …

Main Line Health Researcher Patents New Tools To Detect and Prevent Lyme Disease Read More

Madrigal Pharmaceuticals
Regional

Madrigal Pharmaceuticals Secures Key Patent for Rezdiffra, Extending Market Protection to 2044

July 17, 2025July 16, 2025 - by Timothy Alexander

CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced this week that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a new patent …

Madrigal Pharmaceuticals Secures Key Patent for Rezdiffra, Extending Market Protection to 2044 Read More
Windtree Therapeutics
Regional

Windtree Therapeutics Secures U.S. Patent for Istaroxime Heart Failure Treatment

July 4, 2025July 3, 2025 - by Timothy Alexander

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced that the U.S. Patent and Trademark Office has issued a new patent covering its lead investigational therapy, istaroxime, for intravenous treatment …

Windtree Therapeutics Secures U.S. Patent for Istaroxime Heart Failure Treatment Read More
Palvella Therapeutics
Business

Palvella Therapeutics Secures New Patent for QTORIN™ Rapamycin

June 18, 2025June 18, 2025 - by Timothy Alexander

WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the issuance of U.S. patent No. 12,329,748 by the United States Patent and Trademark Office (USPTO), providing increased protection for its …

Palvella Therapeutics Secures New Patent for QTORIN™ Rapamycin Read More

Posts pagination

1 2 3 Next

Trending News

  • CDC Investigates Listeria Outbreak Tied to Recalled Soft Cheese

  • VA Cuts Prosthetic Approval Steps, Targets Faster Delivery

  • FDA Issues Gene Therapy Guidance Aimed at Faster Reviews

  • Where History Still Walks the Fields: The Enduring Story of Kennett Township

  • CDC Study Links Cosmetic Surgery Tourism to Serious Complications

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Department of Veterans Affairs

VA Cuts Prosthetic Approval Steps, Targets Faster Delivery

7 hours ago15 hours ago

Jamir Garvin

What Led to a Violent Assault Charge in Wilmington?

June 6, 2026June 6, 2026

Hector Soriano-Carela

What Investigators Allege Happened During a Months-Long Drug Probe

June 6, 2026June 6, 2026

Copyright © 2026 MyChesCo.